Tradestie Institutional Equity Comparison Engine

GNPX vs ABTS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GNPX Overall Edge

GNPX Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Genprex, Inc. Common Stock (GNPX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, GNPX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ABTS at N/M Forward P/E and -46.3% operating margin (-20.0% YoY). In options structure, GNPX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABTS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
GNPX N/M vs ABTS N/M Fwd P/E
Growth & Margin Winner GNPX
Op Margin 0.0% vs -46.3% ยท YoY +0.0% vs -20.0%
Momentum & Technical Winner GNPX
1Y -56.6% vs -97.2% ยท 52W Pos 11% vs 0%
Options & Structure Winner GNPX
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
GNPX NASDAQ
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap $2.2M
1M Return -26.77%
1Y Return -56.59%
Forward P/E N/M
Unified AI Score
42.2 / 100 HOLD
Tech 25.0 Fund 47.0 Flow 50.0 Mom 59.0
ABTS NASDAQ
Abits Group Inc Ordinary Shares
Finance Services
$0.17
-31.92% 1D
Market Cap $906,381
1M Return -85.29%
1Y Return -97.15%
Forward P/E N/M
Unified AI Score
46.8 / 100 HOLD
Tech 45.0 Fund 47.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GNPX -56.59% ABTS -97.15% Spread: +40.5 pp (GNPX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GNPX TTM Op. Margin: 0.0% ABTS TTM Op. Margin: -46.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNPX vs ABTS. Trailing 12-month operating profitability (GNPX 0.0% vs ABTS -46.3%) and valuation multiples (GNPX N/M vs ABTS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GNPX (5) vs ABTS (2)
Institutional Metric GNPX ABTS Criterion Row Winner
Market Capitalization Scale $2.2M $906,381 Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -20.0% Higher Growth GNPX
Operating Margin (TTM) Profitability 0.0% -46.3% Higher Margin GNPX
Net Profit Margin Profitability 0.0% -60.8% Higher Margin GNPX
Return on Equity (ROE) Capital Efficiency -233.7% -60.0% Higher ROE ABTS
52-Week Range Position Momentum 11% ($0โ€“$10) 0% ($0โ€“$7) Stronger Trend GNPX
Beta / 30D Volatility Risk Regime -4.68ฮฒ ยท 96% Vol 2.31ฮฒ ยท 233% Vol Lower Realized Risk GNPX
Unified Institutional Score Composite Signal 42.2 / 100 (HOLD) 46.8 / 100 (HOLD) Higher Composite ABTS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GNPX vs ABTS Buy Guide
GNPX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GNPX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABTS BREAKDOWN
118d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABTS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GNPX nor ABTS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.